Literature DB >> 15480701

[LASIK using a scanning spot excimer laser for the treatment of myopia and myopic astigmatism 3-Jahresergebnisse].

T Kohnen1, C Meltendorf, M Cichocki.   

Abstract

PURPOSE: The correction of refractive errors using laser in situ keratomileusis (LASIK) has become the primary refractive procedure worldwide. The purpose of this study was to evaluate LASIK within a retrospective cohort. PATIENTS AND METHODS: The mean preoperative spherical equivalent for the 34 consecutively treated eyes was -6.67+/-2.69 D. The LASIK operations were performed by a Hansatome microkeratome (Bausch and Lomb) and a scanning spot excimer laser (Technolas Keracor 217, Bausch and Lomb). For pre- and postoperative analysis the Datagraph med software (Version 2.7) was used.
RESULTS: None of the treated eyes lost 2 or more lines of best-corrected visual acuity (BCVA). At the 36-month examination the spherical equivalent had changed to -0.47 D (mean increase of myopia: 0.13 D). No long-term complications were found in the study period.
CONCLUSION: LASIK with superior hinge and scanning spot excimer ablation is an effective treatment for the correction of myopia and myopic astigmatism in the refractive range described above.

Entities:  

Mesh:

Year:  2005        PMID: 15480701     DOI: 10.1007/s00347-004-1113-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  12 in total

1.  [Criteria for evaluating and publishing refractive surgery interventions].

Authors:  T Kohnen
Journal:  Klin Monbl Augenheilkd       Date:  1999-12       Impact factor: 0.700

2.  [Scientific evaluation and quality assurance in refractive surgical interventions. Evaluation of the Datagraph med computer program].

Authors:  A Mirshahi; T Kohnen
Journal:  Ophthalmologe       Date:  2002-08       Impact factor: 1.059

3.  Format for reporting refractive surgical data.

Authors:  D D Koch; T Kohnen; S A Obstbaum; E S Rosen
Journal:  J Cataract Refract Surg       Date:  1998-03       Impact factor: 3.351

4.  [Complications of laser in situ keratomileusis (LASIK)].

Authors:  M C Knorz; B Jendritza; P Hugger; A Liermann
Journal:  Ophthalmologe       Date:  1999-08       Impact factor: 1.059

5.  [LASIK with a superior hinge and scanning spot excimer laser ablation for correction of myopia and myopic astigmatism. Results of a prospective study on 100 eyes with a 1-year follow-up].

Authors:  T Kohnen; G W Steinkamp; E M Schnitzler; M Baumeister; G Wellermann; J Bühren; M Brieden; S Herting; A Mirshahi; C Ohrloff
Journal:  Ophthalmologe       Date:  2001-11       Impact factor: 1.059

6.  [LASIK for myopia correction. 2-year follow-up].

Authors:  M C Knorz; B Jendritza; A Liermann; P Hugger; H Liesenhoff
Journal:  Ophthalmologe       Date:  1998-07       Impact factor: 1.059

7.  [Laser in situ keratomileusis (LASIK). Intraoperative and postoperative complications].

Authors:  H Petersen; T Seiler
Journal:  Ophthalmologe       Date:  1999-04       Impact factor: 1.059

8.  [Photoastigmatic refractive keratectomy for low, moderate, and high astigmatism using a broad beam excimer laser: evaluataion according to new international criteria].

Authors:  E M Schnitzler; T Kohnen; G W Steinkamp; C Ohrloff
Journal:  Klin Monbl Augenheilkd       Date:  1999-11       Impact factor: 0.700

9.  Six-year follow-up of laser in situ keratomileusis for moderate and extreme myopia using a first-generation excimer laser and microkeratome.

Authors:  Walter Sekundo; Katrin Bönicke; Peter Mattausch; Wolfgang Wiegand
Journal:  J Cataract Refract Surg       Date:  2003-06       Impact factor: 3.351

10.  [Laser in situ keratomileusis for correction of hyperopia and hyperopic astigmatism using a scanning spot excimer laser. Results of a prospective clinical study after 1 year].

Authors:  T Kohnen; A Mirshahi; M Cichocki; J Bühren; G W K Steinkamp
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

View more
  1 in total

1.  Basic knowledge of refractive surgery: correction of refractive errors using modern surgical procedures.

Authors:  Thomas Kohnen; Anja Strenger; Oliver K Klaproth
Journal:  Dtsch Arztebl Int       Date:  2008-02-29       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.